Douglas E.  Coltharp net worth and biography

Douglas Coltharp Biography and Net Worth

Douglas (Doug) E. Coltharp was named chief financial officer on May 6, 2010. Prior to joining Encompass Health, Coltharp served as a partner at Arlington Capital Advisors and Arlington Investment Partners, LLC, a boutique investment banking and private equity firm. Coltharp also served 11 years as executive vice president and chief financial officer for Saks Inc. In this role, he was responsible for recapitalizing the company and guiding it through a series of acquisitions and organic growth strategies that transformed it from a small cap, regional department store operator to a Fortune 1000 national retailer. Coltharp began his career in 1987 at Nations Bank, N.A. (now part of Bank of America) and rose to become senior vice president and head of Southeast Corporate Banking. During this time, he advised Fortune 1000 companies on capital raising and other corporate financial matters. Coltharp graduated from Lehigh University with a bachelor’s degree in finance and economics and earned his master’s in business administration with concentrations in finance and strategic planning from the Wharton School, University of Pennsylvania.

What is Douglas E. Coltharp's net worth?

The estimated net worth of Douglas E. Coltharp is at least $13.95 million as of August 13th, 2024. Mr. Coltharp owns 136,227 shares of Encompass Health stock worth more than $13,946,239 as of December 3rd. This net worth approximation does not reflect any other assets that Mr. Coltharp may own. Additionally, Mr. Coltharp receives an annual salary of $1,830,000.00 as CFO at Encompass Health. Learn More about Douglas E. Coltharp's net worth.

How old is Douglas E. Coltharp?

Mr. Coltharp is currently 62 years old. There are 4 older executives and no younger executives at Encompass Health. The oldest executive at Encompass Health is Dr. Elissa Joy Charbonneau D.O., M.S., Chief Medical Officer, who is 64 years old. Learn More on Douglas E. Coltharp's age.

What is Douglas E. Coltharp's salary?

As the CFO of Encompass Health Co., Mr. Coltharp earns $1,830,000.00 per year. The highest earning executive at Encompass Health is Mr. Mark J. Tarr, CEO, President & Director, who commands a salary of $3,430,000.00 per year. Learn More on Douglas E. Coltharp's salary.

How do I contact Douglas E. Coltharp?

The corporate mailing address for Mr. Coltharp and other Encompass Health executives is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. Encompass Health can also be reached via phone at (205) 967-7116 and via email at [email protected]. Learn More on Douglas E. Coltharp's contact information.

Has Douglas E. Coltharp been buying or selling shares of Encompass Health?

Douglas E. Coltharp has not been actively trading shares of Encompass Health over the course of the past ninety days. Most recently, Douglas E. Coltharp sold 12,260 shares of the business's stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $86.34, for a transaction totalling $1,058,528.40. Following the completion of the sale, the chief financial officer now directly owns 136,227 shares of the company's stock, valued at $11,761,839.18. Learn More on Douglas E. Coltharp's trading history.

Who are Encompass Health's active insiders?

Encompass Health's insider roster includes Greg Carmichael (Director), Elissa Charbonneau (Insider), Douglas Coltharp (CFO), John Darby (EVP,General Counsel & Corporate Secretary), Kevin O'Connor (Director), Andrew Price (CAO), Mark Tarr (CEO), and Terrance Williams (Director). Learn More on Encompass Health's active insiders.

Are insiders buying or selling shares of Encompass Health?

In the last year, Encompass Health insiders bought shares 1 times. They purchased a total of 2,000 shares worth more than $167,460.00. In the last year, insiders at the sold shares 4 times. They sold a total of 81,779 shares worth more than $6,874,619.34. The most recent insider tranaction occured on August, 13th when CFO Douglas E Coltharp sold 12,260 shares worth more than $1,058,528.40. Insiders at Encompass Health own 2.1% of the company. Learn More about insider trades at Encompass Health.

Information on this page was last updated on 8/13/2024.

Douglas E. Coltharp Insider Trading History at Encompass Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/13/2024Sell12,260$86.34$1,058,528.40136,227View SEC Filing Icon  
11/13/2023Sell11,215$63.39$710,918.85116,293View SEC Filing Icon  
2/10/2023Sell17,895$60.78$1,087,658.1053,097View SEC Filing Icon  
11/9/2016Buy6,450$39.14$252,453.00104,637View SEC Filing Icon  
See Full Table

Douglas E. Coltharp Buying and Selling Activity at Encompass Health

This chart shows Douglas E Coltharp's buying and selling at Encompass Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Encompass Health Company Overview

Encompass Health logo
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
Read More

Today's Range

Now: $102.09
Low: $101.76
High: $102.74

50 Day Range

MA: $98.16
Low: $92.82
High: $103.77

2 Week Range

Now: $102.09
Low: $64.15
High: $104.55

Volume

75,638 shs

Average Volume

637,345 shs

Market Capitalization

$10.29 billion

P/E Ratio

24.66

Dividend Yield

0.66%

Beta

0.86